| Year |
Citation |
Score |
| 2020 |
de Jong JJ, Boormans JL, van Rhijn BWG, Seiler R, Boorjian SA, Konety B, Bivalacqua TJ, Wheeler T, Svatek RS, Douglas J, Wright J, Dall'Era M, Crabb SJ, Efstathiou JA, van der Heijden MS, et al. Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific Differences. European Urology Oncology. PMID 32205136 DOI: 10.1016/J.Euo.2020.02.010 |
0.324 |
|
| 2020 |
Nyame Y, Wang X, Jordahl K, Dai J, Troyer D, Lance R, Wright J, Stanford J. Pd52-05 Assessing Pam50 Molecular Subtypes By Race And Outcomes In Men With Localized Prostate Cancer The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000954.05 |
0.321 |
|
| 2019 |
Nyame Y, Holt S, Winters B, Psutka S, Dash A, Schade G, Lin D, Yu E, Gore J, Wright J. Pd57-06 Neoadjuvant Chemotherapy Utilization In Muscle-Invasive Bladder Cancer: Associations Between Socioeconomic Status, Ethnicity, And Utilization? The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000557162.21059.5C |
0.319 |
|
| 2019 |
Costa JBD, Gibb EA, Bivalacqua TJ, Liu Y, Oo HZ, Miyamoto DT, Alshalalfa M, Davicioni E, Wright J, Dall’Era MA, Douglas J, Boormans L, Heijden MSVD, Wu C, Rhijn BWGV, et al. Molecular characterization of neuroendocrine-like bladder cancer European Urology Supplements. 18. DOI: 10.1016/S1569-9056(19)30464-6 |
0.348 |
|
| 2018 |
Lotan Y, Wright J, Dall'Era MA, Bivalacqua T, Seiler R, Liu Y, Gibb E, Wang Q, Erho N, Alshalalfa M, Davicioni E, Efstathiou JA, Douglas J, Boormans JL, Van der Heijden MS, et al. MP58-19 A GENOMIC CLASSIFIER FOR IDENTIFYING A NEUROENDOCRINE-LIKE BLADDER CANCER SUBTYPE Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1851 |
0.326 |
|
| 2018 |
Lam H, Liu Y, Vakar-Lopez F, Brown L, Montgomery B, Corey E, Hsieh A, Wright J. Mp54-14 Characterization Of Human Bladder Cancer Patient-Derived Xenograft In Vivo And In Organoids The Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1705 |
0.335 |
|
| 2017 |
Seiler R, Ashab HA, Erho N, van Rhijn BW, Winters B, Douglas J, Van Kessel KE, Fransen van de Putte EE, Sommerlad M, Wang NQ, Choeurng V, Gibb EA, Palmer-Aronsten B, Lam LL, Buerki C, ... ... Wright J, et al. Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy. European Urology. PMID 28390739 DOI: 10.1016/J.Eururo.2017.03.030 |
0.33 |
|
| 2017 |
Seiler R, Ashab H, Erho N, Van Rhijn B, Winters B, Douglas J, Van Kessel K, Fransen Van De Putte E, Sommerlad M, Wang Q, Choeurng V, Gibb E, Palmer-Aronsten B, Lam L, Buerki C, ... ... Wright J, et al. Muscle invasive bladder cancer: A single sample patient assay to predict molecular subtypes and benefit of neoadjuvant chemotherapy European Urology Supplements. 16: e1567-e1568. DOI: 10.1016/S1569-9056(17)30952-1 |
0.327 |
|
| 2017 |
Seiler R, Gibb EA, Takhar M, Kessel KV, van Rhijn BW, Winters B, Douglas J, Wang Q, Choeurng V, Erho N, Buerki C, Davicioni E, Sjödahl G, Thalmann GN, Zwarthoff EC, ... ... Wright J, et al. Plasticity in muscle-invasive bladder cancer before and after cisplatin-based neoadjuvant chemotherapy Urologic Oncology: Seminars and Original Investigations. 35: 618. DOI: 10.1016/J.Urolonc.2017.06.034 |
0.328 |
|
| 2017 |
Winters B, Kearns J, Holt S, Mossanen M, Lin D, Wright J. Mp80-05 Is There Benefit To Adjuvant Radiation In Stage Iii Penile Cancer After Lymph Node Dissection? Findings From The National Cancer Database. The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.2510 |
0.317 |
|
| 2017 |
Kearns J, Winters B, Lin D, Wright J. PD49-05 PATHOLOGICAL NODAL INVOLVEMENT IN PATIENTS WITH PENILE CANCER IN THE NATIONAL CANCER DATA BASE (NCDB) USING THE UPDATED AJCC STAGING GUIDELINES FOR T2 AND T3 DISEASE Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.2229 |
0.315 |
|
| 2017 |
Kearns J, Holt S, Wright J, Lin D, Lange P, Gore J. Pd43-12 Psa Screening, Prostate Biopsy, And Treatment Of Prostate Cancer In The Years Surrounding The Uspstf Recommendation Against Prostate Cancer Screening The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1917 |
0.305 |
|
| 2017 |
Seiler R, Ashab HAD, Erho N, Rhijn BWGv, Winters B, Douglas J, Kessel KV, Putte EEFvd, Sommerlad M, Wang Q, Choeurng V, Gibb EA, Palmer-Aronsten B, Lam LL, Buerki C, ... ... Wright J, et al. Mp34-01 Molecular Subtypes Of Muscle Invasive Bladder Cancer Are Related To Benefit From Neoadjuvant Chemotherapy: Development Of A Single Sample Patient Assay The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1018 |
0.33 |
|
| 2016 |
Lynch J, Rothney M, Salup R, Ercole C, Mathur S, Duchene D, Basler J, Hernandez J, Liss M, Porter M, Wright J, Risk M, Garzotto M, Efimova O, Barrett L, et al. Impact of the 17-Gene Genomic Prostate Score Assay on Low Risk Prostate Cancer Patients in the Veterans Health Care Administration Value in Health. 19. DOI: 10.1016/J.Jval.2016.03.1521 |
0.308 |
|
| 2015 |
Winters B, Schade G, Holt S, Lin D, Ellis W, Dalkin B, Wright J. PD46-12 PROSTATE CANCER UPGRADING AT PROSTATECTOMY: A POPULATION-BASED ANALYSIS OF > 25,000 MEN Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2743 |
0.311 |
|
| 2015 |
Winters B, Holt S, Lin D, Porter M, Cheng H, Wright J. PD46-04 TREATMENT AND SURVIVAL IN MEN UNDER AGE 55 YEARS DIAGNOSED WITH GLEASON 8-10 PROSTATE CANCER: IMPLICATIONS OF PSA SCREENING Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2735 |
0.314 |
|
| 2015 |
Welty C, Sanford T, Wright J, Carroll P, Meng M, Porten S. Pd41-10 The Impact Of Tumor Stage On Cancer Specific Survival In Patients With Node Positive Urothelial Cancer Of The Bladder The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2418 |
0.352 |
|
| 2015 |
Winters B, Holt S, Zhang X, Morrissey C, Lin D, Plymate S, Wright J. MP55-14 METFORMIN USE AND METABOLIC SIGNALING IN MEN UNDERGOING PROSTATE NEEDLE BIOPSY Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2057 |
0.312 |
|
| 2015 |
Nayak J, Holt S, Wright J, Dash A, Gore J. MP24-18 THE IMPACT OF READMISSIONS TO SECONDARY HOSPITALS ON FAILURE-TO-RESCUE RATES FOLLOWING MAJOR UROLOGIC CANCER SURGERY Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1160 |
0.302 |
|
| 2013 |
James A, Lee F, Harris W, Cheng H, Zhao S, Gore J, Lin D, Porter M, Yu E, Wright J. 1443 ROLE OF COMPLETE TRANSURETHRAL RESECTION IN BLADDER CANCER PRIOR TO CYSTECTOMY: IS THERE BENEFIT WHEN GIVING NEOADJUVANT CHEMOTHERAPY? Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.2797 |
0.35 |
|
| 2013 |
James A, Wright J, Porter M, Holt S, Gore J. 1442 BURDEN OF VENOTHROMBOTIC EVENTS IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR BLADDER CANCER Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.2796 |
0.348 |
|
| 2013 |
Wright J, Chery L, Lin D, Holt S, Luedeke M, Rinckleb A, Maier C, Stanford J. 2139 ASPIRIN USE REDUCES RISK OF TMPRSS2:ERG FUSION POSITIVE PROSTATE CANCER Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.2048 |
0.317 |
|
| 2012 |
Gore J, Wright J, Izard J, Harper J, Porter M. 412 Identification Of Underserved Areas For Urologic Cancer Care The Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.478 |
0.303 |
|
| 2012 |
Welty C, Bhatti P, Porter M, White E, Wright J. 1901 Increased Risk Of Mortality From Squamous Cell Carcinoma Of The Bladder Among Women In The United States The Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.2057 |
0.31 |
|
| 2011 |
Salazar M, Chatterjee S, Lin D, Wright J. 154 POSITIVE SURGICAL MARGINS AT RADICAL PROSTATECTOMY: NATIONAL AVERAGES WITHIN PSA AND GLEASON STRATA Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.222 |
0.318 |
|
| 2007 |
Hanson G, Wright J, Kim J, Borden LS, Porter CR. Is age an independent predictor of clincially significant prostate cancer in a referral population? A case for needle biopsy in the elderly Journal of Clinical Oncology. 25: 5142-5142. DOI: 10.1200/Jco.2007.25.18_Suppl.5142 |
0.314 |
|
| 2006 |
Wright J, Lin D, Cowan J, DuChane J, Carroll P, Litwin. Puk12 Quality Of Life In Young Men After Radical Prostatectomy For Clinically Localized Prostate Cancer: Results From The Capsure Registry Value in Health. 9. DOI: 10.1016/S1098-3015(10)64611-6 |
0.312 |
|
| Show low-probability matches. |